Cargando…

A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan

PURPOSE: To evaluate the cost-effectiveness of pregabalin versus other analgesics among patients with chronic cervical pain with neuropathic components during routine clinical practice in Japan. PATIENTS AND METHODS: The analysis considered patients with chronic cervical pain with a neuropathic pain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akazawa, Manabu, Igarashi, Ataru, Ebata, Nozomi, Murata, Tatsunori, Zeniya, Shigeki, Haga, Yuri, Nozawa, Kazutaka, Fujii, Koichi, Taguchi, Toshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765214/ https://www.ncbi.nlm.nih.gov/pubmed/31576163 http://dx.doi.org/10.2147/JPR.S203712

Ejemplares similares

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan
por: Igarashi, Ataru, et al.
Publicado: (2015)

Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan
por: Taguchi, Toshihiko, et al.
Publicado: (2015)

Direct and Indirect Pathways for Health-Related Quality of Life Change from Pain Improvement in Neuropathic Pain Patients with Spine Diseases: Path Analysis with Structural Equation Modeling Using Non-Interventional Study Results of Pregabalin
por: Taguchi, Toshihiko, et al.
Publicado: (2021)

Effectiveness of pregabalin for treatment of chronic cervical radiculopathy with upper limb radiating pain: an 8-week, multicenter prospective observational study in Japanese primary care settings
por: Taguchi, Toshihiko, et al.
Publicado: (2019)

Effectiveness of Pregabalin Treatment for Neuropathic Pain in Patients with Spine Diseases: A Pooled Analysis of Two Multicenter Observational Studies in Japan
por: Taguchi, Toshihiko, et al.
Publicado: (2021)

Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan
por: Karasawa, Yusuke, et al.
Publicado: (2021)

The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain
por: Parsons, Bruce, et al.
Publicado: (2019)

Clinical and economic burdens experienced by patients with painful diabetic peripheral neuropathy: An observational study using a Japanese claims database
por: Ebata-Kogure, Nozomi, et al.
Publicado: (2017)

Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study
por: Akazawa, Manabu, et al.
Publicado: (2019)

Efficacy of Combination Therapy with Pregabalin in Neuropathic Pain: A Preclinical Study in the Rat L5 Spinal Nerve Ligation Model
por: Nozawa, Kazutaka, et al.
Publicado: (2022)

Pregabalin in Chemotherapy Induced Neuropathic Pain
por: Atreya, Shrikant
Publicado: (2016)

Morphine and pregabalin in the treatment of neuropathic pain
por: Wang, Yue, et al.
Publicado: (2017)

Pregabalin Prescription for Neuropathic Pain and Fibromyalgia: A Descriptive Study Using Administrative Database in Japan
por: Hirakata, Mikito, et al.
Publicado: (2018)

Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan
por: Yuki, Takumoto, et al.
Publicado: (2022)

Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
por: Verma, Vivek, et al.
Publicado: (2014)

Correction: Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan
por: Takumoto, Yuki, et al.
Publicado: (2023)

Synergistic Antinociceptive Effects of Indomethacin–Pregabalin and Meloxicam–Pregabalin in Paclitaxel-Induced Neuropathic Pain
por: Ma, Yurong, et al.
Publicado: (2022)

Clinical use of pregabalin in the management of central neuropathic pain
por: Finnerup, Nanna B, et al.
Publicado: (2007)

Pregabalin in post traumatic neuropathic pain: Case studies
por: Singh, Rakesh Kumar, et al.
Publicado: (2012)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
por: Gül, Şule Karabulut, et al.
Publicado: (2020)

Pregabalin in the Treatment of Peripheral and Central Chronic Neuropathic Pain
por: Prnjavorac, Besim, et al.
Publicado: (2023)

The association between lower back pain and health status, work productivity, and health care resource use in Japan
por: Sadosky, Alesia B, et al.
Publicado: (2015)

Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin
por: Enomoto, Hiroyuki, et al.
Publicado: (2018)

Use of Anticancer Therapies and Economic Burden Near the End of Life in Japan: Results From Claims Database
por: Kajimoto, Yusuke, et al.
Publicado: (2022)

Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in Japan
por: Takushima, Yusuke, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2021)

Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2012)

A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain
por: Freynhagen, Rainer, et al.
Publicado: (2015)

The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system
por: Kremer, Mélanie, et al.
Publicado: (2016)

Pregabalin treatment for neuropathic pain may damage intervertebral disc tissue
por: Karaarslan, Numan, et al.
Publicado: (2018)

Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin
por: Shimada, Yohei, et al.
Publicado: (2017)

Perioperative Analgesics and Anesthesia as Risk Factors for Postoperative Chronic Opioid Use in Patients Undergoing Total Knee Arthroplasty: A Retrospective Cohort Study Using Japanese Hospital Claims Data
por: Nozawa, Kazutaka, et al.
Publicado: (2023)

Retraction: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2014)

Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience
por: Dongre, Yasmin U, et al.
Publicado: (2013)

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
por: Haanpää, M., et al.
Publicado: (2015)

Factors predicting adverse events associated with pregabalin administered for neuropathic pain relief
por: Kanbayashi, Yuko, et al.
Publicado: (2014)

Reduction in medical costs for cardiovascular diseases through innovative health awareness projects in a rural area in Japan
por: Shoji, Ayako, et al.
Publicado: (2022)

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022)

Antiallodynic Effect of Pregabalin in Rat Models of Sympathetically Maintained and Sympathetic Independent Neuropathic Pain
por: Han, Dong Woo, et al.
Publicado: (2007)

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jolb5dcj42n1um920ctv3ofu7k